Prostate cancer

01 April 2010

Study Revives Debate on Prostate Drug

Experts disagree on whether medication cuts cancer risk

This article has not necessarily been edited by Health24.

The results of the four-year study of the effect of Avodart on prostate -- financed by Glaxo, which markets the drug -- seem to mirror those of a 19,000-participant study in 2003 of finasteride (Propecia), which found a 25 percent lower incidence of prostate cancer among men who took that drug than among those who took a placebo.


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.